Baird Financial Group’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $351K | Sell |
|
|||||
|
2025
Q2 | $327K | Sell |
|
|||||
|
2025
Q1 | $652K | Hold |
|
|||||
|
2024
Q4 | $1.45M | Buy |
|
|||||
|
2024
Q3 | $1.82M | Buy |
|
|||||
|
2024
Q2 | $1.1M | Buy |
|
|||||
|
2024
Q1 | $160K | Hold |
|
|||||
|
2023
Q4 | $87.8K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $183K | Sell |
|
|||||
|
2022
Q2 | $212K | Sell |
|
|||||
|
2022
Q1 | $459K | Buy |
|
|||||
|
2021
Q4 | $507K | Sell |
|
|||||
|
2021
Q3 | $766K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $232K | Sell |
|
|||||
|
2020
Q4 | $1.94M | Buy |
|
|||||
|
2020
Q3 | $1.09M | Buy |
|
|||||
|
2020
Q2 | $797K | Buy |
|
|||||
|
2020
Q1 | $331K | Buy |
|